[HTML][HTML] Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): new opportunities in establishing faithful pre-clinical cancer models
One of the major bottlenecks in advancing basic cancer research and developing novel
cancer therapies is the lack of in vitro pre-clinical models that faithfully recapitulate tumor …
cancer therapies is the lack of in vitro pre-clinical models that faithfully recapitulate tumor …